For Hyal1, it has been confirmed to present abnormal expression in bladder carcinoma, pancreatic carcinoma and other diseases [15–17], but there is still a lack of relevant studies to confirm its exact role in occurrence and development of CRC. This evidence concerns the gene HYAL1 and colorectal carcinoma.